German Cancer Aid Award for Galina Selivanova

Galina Selivanova has been awarded 20, 000 Euros from German Cancer Aid (Stiftung Für Die Erforschung ung Bekämpfung der Krebsklarnkheiten) for research described in the paper "ROS-dependent activation of JNK converts p53 into an efficient inhibitor of oncogenes leading to robust apoptosis" published in Cell Death Differ, April 2014

German Cancer Aid is Germany’s leading non-governmental funding and non-profit-making organization of oncology-related activities.

More information

ROS-dependent activation of JNK converts p53 into an efficient inhibitor of oncogenes leading to robust apoptosis.
Shi Y, Nikulenkov F, Zawacka-Pankau J, Li H, Gabdoulline R, Xu J, et al
Cell Death Differ. 2014 Apr;21(4):612-23

German Cancer Aid website

Galina Selivanova research group website